From Bariatric to Metabolic Surgery: Definition of a New Discipline and Implications for Clinical Practice

被引:0
作者
Francesco Rubino
机构
[1] King’s College London,
[2] Catholic University of Rome,undefined
来源
Current Atherosclerosis Reports | 2013年 / 15卷
关键词
Obesity; Diabetes; Metabolic surgery; Bariatric surgery; Gastric bypass; Sleeve gastrectomy; Gastric banding;
D O I
暂无
中图分类号
学科分类号
摘要
Bariatric surgery indicates a variety of gastrointestinal (GI) surgical procedures originally designed to induce weight reduction in morbidly obese patients. Benefits of bariatric surgery, however, extend well beyond weight loss and include dramatic improvement of type 2 diabetes, hypertension, dyslipidemia, and reduction of overall mortality. Furthermore, studies in rodents and humans show that the anti-diabetes effect of certain bariatric procedures results from a variety of neuroendocrine and metabolic mechanisms secondary to changes in GI anatomy. The recognition that benefits and mechanisms of GI operations are not limited to weight reduction provided a rationale for the emergence of metabolic surgery intended as a surgical approach primarily aimed to the treatment of diabetes and metabolic disease. Consistent with the goals of improving glycemic and metabolic control, in contrast to mere weight loss, metabolic surgery implies the development of a new model of care distinct from traditional bariatric surgery. This paper discusses the definition of metabolic surgery and its clinical practice.
引用
收藏
相关论文
共 214 条
[21]  
Swanson MS(2013)Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass Science 341 406-8
[22]  
Pories WJ(2007)Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2 Surg Obes Relat Dis 3 195-23
[23]  
Swanson MS(2012)Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity Diabetes Care 35 1420-85
[24]  
MacDonald KG(2008)Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial JAMA 299 316-76
[25]  
Long SB(2012)Bariatric surgery versus conventional medical therapy for type 2 diabetes N Engl J Med 366 1577-9
[26]  
Morris PG(2012)Bariatric surgery versus intensive medical therapy in obese patients with diabetes N Engl J Med 366 1567-52
[27]  
Brown BM(2013)Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial JAMA 309 2240-65
[28]  
Scopinaro N(2007)Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 357 741-405
[29]  
Adami GF(2012)Bariatric surgery and long-term cardiovascular events JAMA 307 56-90
[30]  
Marinari GM(2010)The Diabetes Surgery Summit Consensus Conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus Ann Surg 251 399-51